Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$479M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$415M |
| 3 |
Apple
AAPL
|
+$313M |
| 4 |
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
|
+$292M |
| 5 |
JPMorgan Chase
JPM
|
+$282M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$393M |
| 2 |
American Tower
AMT
|
+$282M |
| 3 |
Wells Fargo
WFC
|
+$268M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$241M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.56% |
| 2 | Healthcare | 12.1% |
| 3 | Financials | 10.73% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Agilent Technologies
A
$42B
| $50M | 0.02% |
565,412
-101,319
| -15% | -$8.3M |
|
627
Emerson Electric
EMR
$88.5B
| $49.7M | 0.02% |
799,464
-90,814
| -10% | -$5.16M |
|
|
WPX
628
DELISTED
WPX Energy, Inc.
WPX
| $49.2M | 0.02% |
7,713,982
+1,254,344
| +19% | +$7.08M |
|
|
WBA
629
DELISTED
Walgreens Boots Alliance
WBA
| $49.1M | 0.02% |
1,157,214
-864,880
| -43% | -$36.7M |
|
|
PXD
630
DELISTED
Pioneer Natural Resource Co.
PXD
| $48.8M | 0.02% |
498,551
+48,978
| +11% | +$4.32M |
|
631
Teladoc Health
TDOC
$1.29B
| $48.8M | 0.02% |
254,964
-333,596
| -57% | -$58.5M |
|
632
Casella Waste Systems
CWST
$5.72B
| $48.4M | 0.02% |
931,207
+62,662
| +7% | +$2.99M |
|
633
ePlus
PLUS
$2.35B
| $48.4M | 0.02% |
1,368,822
+15,208
| +1% | +$519K |
|
634
10x Genomics
TXG
$7.44B
| $48.3M | 0.02% |
540,877
+347,974
| +180% | +$27.1M |
|
635
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.99B
| $48.3M | 0.02% |
723,460
+31,826
| +5% | +$2M |
|
636
DexCom
DXCM
$33.1B
| $48.2M | 0.02% |
475,964
+2,100
| +0.4% | +$188K |
|
|
PENG
637
Penguin Solutions Inc
PENG
$2.83B
| $48.1M | 0.02% |
3,536,814
+373,378
| +12% | +$4.76M |
|
638
NeoGenomics
NEO
$2.14B
| $47.8M | 0.02% |
1,541,962
+832,534
| +117% | +$23.1M |
|
639
Unifirst Corp
UNF
$5.24B
| $47.7M | 0.02% |
266,482
-4,505
| -2% | -$755K |
|
640
Protolabs
PRLB
$2.14B
| $47.5M | 0.02% |
422,420
-50,225
| -11% | -$5.16M |
|
641
QuidelOrtho
QDEL
$938M
| $47.3M | 0.02% |
211,253
-6,457
| -3% | -$1.01M |
|
642
Viavi Solutions
VIAV
$9.18B
| $47.3M | 0.02% |
3,710,860
-372,129
| -9% | -$4.46M |
|
|
EQC
643
DELISTED
Equity Commonwealth
EQC
| $47.3M | 0.02% |
1,467,475
+58,038
| +4% | +$1.92M |
|
644
Neurocrine Biosciences
NBIX
$16.8B
| $47.2M | 0.02% |
378,317
+13,178
| +4% | +$1.46M |
|
645
Iron Mountain
IRM
$36.2B
| $47M | 0.02% |
1,763,971
-58,952
| -3% | -$1.49M |
|
646
iShares Select Dividend ETF
DVY
$23.6B
| $46.7M | 0.02% |
577,168
+68,164
| +13% | +$5.45M |
|
647
Cameco
CCJ
$42.4B
| $46.7M | 0.02% |
4,551,904
+657,478
| +17% | +$6.57M |
|
|
LTHM
648
DELISTED
Livent Corporation
LTHM
| $46.3M | 0.02% |
7,526,014
+2,012,136
| +36% | +$12.7M |
|
649
Cognizant
CTSH
$26.3B
| $46.3M | 0.02% |
813,820
-8,606
| -1% | -$462K |
|
|
NVO
650
Novo Nordisk
NVO
$211B
| $46.1M | 0.02% |
1,408,844
-1,332,088
| -49% | -$42.5M |
|
Similar funds
Ameriprise's Q2 2020 Portfolio in Review
As of Q2 2020, Ameriprise held 3,808 positions worth $233B, up 23% from $190B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ameriprise's Q2 2020 filing shows 183 new, 1,548 increased, 1,847 reduced and 139 closed positions. Its largest new stake was Carrier Global: 9,308,867 shares worth $207M. The largest sale was Verizon, an estimated $393M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2020 buy was Carrier Global: 9,308,867 shares worth $207M.
- Ameriprise added most to TE Connectivity in Q2 2020, an estimated $479M increase.
- Ameriprise's biggest Q2 2020 reduction was Verizon, cutting an estimated $393M.
- Ameriprise fully exited Allergan plc in Q2 2020, selling an estimated $124M.
- Ameriprise's ten largest holdings make up 17% of its $233B portfolio in Q2 2020.
- Ameriprise opened 183 new positions and closed 139 in Q2 2020.
- Ameriprise's portfolio value rose 23% quarter-over-quarter to $233B.
Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.